AVITA Medical, Inc. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
AVITA Medical, Inc. (RCEL) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $9.82 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-02-12
- AVITA Medical, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $9.82M.
- AVITA Medical, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was -$5.78M, a 202.85% decline from fiscal 2023.
- AVITA Medical, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $5.62M, a 14.64% increase from fiscal 2022.
- AVITA Medical, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $4.90M.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 6 month | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month |
|---|---|---|
| 2025-12-31 | $9.82M 10-K · filed 2026-02-12 | |
| 2024-12-31 | -$5.78M 10-K · filed 2026-02-12 | |
| 2023-12-31 | $5.62M 10-K · filed 2025-02-13 | |
| 2022-12-31 | $4.90M 10-K · filed 2024-02-22 | |
| 2021-12-31 | $1.99M 10-K · filed 2023-02-23 | |
| 2021-06-30 | $5.38M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $3.32M 10-KT · filed 2022-02-28 | |
| 2020-06-30 | $13.34M 10-KT · filed 2022-02-28 | |
| 2019-06-30 | $4.98M 10-K · filed 2021-08-26 | |
| 2018-06-30 | -$326.00K 10-K · filed 2020-08-27 |